8Suppliers
2Customers
2Debt Items
12Related Chains

CV Sciences, Inc. Suppliers

TickerNameConfidenceEvidence
INVESTOR INVESTOR 92% the Company issued and sold to the Investor a secured promissory note in the original principal amount of $1,600,000
FIRST-INSURANCE FIRST-INSURANCE 90% In October 2024, the Company entered into a finance agreement with First Insurance in order to fund a portion of its insurance policies for the most recent policy year.
FIRST-INSURANCE-FUNDING FIRST-INSURANCE-FUNDING 90% In October 2025, the Company entered into a finance agreement with First Insurance Funding ("First Insurance") in order to fund a portion of its insurance policies for the upcoming policy year.
ONE-CONTRACT-MANUFACTURER ONE-CONTRACT-MANUFACTURER 90% In addition, one supplier of shipping and fulfillment services and one contract manufacturer accounted for 16 % each of our outstanding accounts payable as of December 31, 2025.
ONE-PROVIDER-OF-LEGAL-SERVICES ONE-PROVIDER-OF-LEGAL-SERVICES 90% One provider of legal services accounted for 41 % and 28 % of our outstanding accounts payable as of December 31, 2025 and 2024, respectively.
ONE-SUPPLIER-OF-SHIPPING-AND-FULFILLMENT-SERVICE ONE-SUPPLIER-OF-SHIPPING-AND-FULFILLMENT-SERVICE 90% In addition, one supplier of shipping and fulfillment services and one contract manufacturer accounted for 16 % each of our outstanding accounts payable as of December 31, 2025.
HRMY Harmony Biosciences Holdings, Inc. 72% ales for the years ended December 31, 2024 and 2023, respectively. As a result, we do not believe our financial condition and results of operations is dependent on any one particular major customer. …
HRMY Harmony Biosciences Holdings, Inc. 72% Reciprocal relationship from HRMY graph: Reciprocal relationship from CVSI graph: ales for the years ended December 31, 2024 and 2023, respectively. As a result, we do not believe our financial condi…

CV Sciences, Inc. Customers

TickerNameConfidenceEvidence
HRMY Harmony Biosciences Holdings, Inc. 72% ales for the years ended December 31, 2024 and 2023, respectively. As a result, we do not believe our financial condition and results of operations is dependent on any one particular major customer. …
HRMY Harmony Biosciences Holdings, Inc. 72% Reciprocal relationship from HRMY graph: Reciprocal relationship from CVSI graph: ales for the years ended December 31, 2024 and 2023, respectively. As a result, we do not believe our financial condi…

CV Sciences, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
CVSI-DEBT-8961 Warrants outstanding: 10000000 90% xbrl warrant detail from xbrl 2022-03-30.
CVSI-DEBT-8962 Xbrl Convertible 90% xbrl convertible detail from xbrl 2023-12-31.

CV Sciences, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for CV Sciences, Inc..

CV Sciences, Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for CV Sciences, Inc..

CV Sciences, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
CAH Cardinal Health, Inc. 100.00 2
OVATF Ovation Science Inc. 100.00 2
DYN Dyne Therapeutics, Inc. 100.00 2
XYF X Financial 100.00 2
STVN Stevanato Group S.p.A. 50.00 2
ORANY ORANGE 50.00 2
RAYNE RAYNE 50.00 2
HRMY Harmony Biosciences Holdings, Inc. 38.88 1 ['customer', 'supplier']
EDXC Endexx Corporation 36.29 1 ['spend']
KHODE KHODE 16.04 2
SPRC SciSparc Ltd. 14.78 2
TMO Thermo Fisher Scientific Inc. 14.78 2